Abstract
The aim of this study was to investigate the effect of deer bone oil extract (DBOE) on lipopolysaccharide (LPS)-induced inflammatory responses in RAW264.7 cells. DBOE was fractionated by liquid-liquid extraction to obtain two fractions: methanol fraction (DBO-M) and hexane fraction (DBO-H). TLC showed that DBO-M had relatively more hydrophilic lipid complexes, including unsaturated fatty acids, than DBOE and DBO-H. The relative compositions of tetradecenoyl carnitine, α-linoleic acid, and palmitoleic acid increased in the DBO-M fraction by 61, 38, and 32%, respectively, compared with DBOE. The concentration of sugar moieties was 3-fold higher in the DBO-M fraction than DBOE and DBO-H. DBO-M significantly decreased LPS-induced nitric oxide (NO) production in RAW264.7 cells in a dose-dependent manner. This DBO-M-me-diated decrease in NO production was due to downregulation of mRNA and protein levels of inducible nitric oxide synthase (iNOS). In addition, mRNA expression of pro-inflammatory mediators, such as cyclooxygenase (COX-2), interleukin (IL)-1β, and IL-12β, was suppressed by DBO-M. Our data showed that DBO-M, which has relatively higher sugar content than DBOE and DBO-H, could play an important role in suppressing inflammatory responses by controlling pro-inflammatory cytokines and mediators.
Original language | English |
---|---|
Pages (from-to) | 593-600 |
Number of pages | 8 |
Journal | Biological and Pharmaceutical Bulletin |
Volume | 39 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2016 Apr |
Bibliographical note
Publisher Copyright:© 2016 The Pharmaceutical Society of Japan.
Keywords
- Anti-inflammatory response
- Deer bone oil extract (DBOE)
- Inducible nitric oxide synthase (iNOS)
- Nitric oxide (NO)
- RAW264.7
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science